Semaglutide 2.4 mg (Wegovy), more recently approved and recommended by NICE (TA875), demonstrates superior efficacy with mean weight loss of approximately 1215% (placebo-subtracted ~10%) in clinical trials
However, it is crucial to recognize that sustained weight management may necessitate ongoing treatment
Your dose may need to go up, but your price won't, eliminating cost barriers to reaching your therapeutic level
Our weight loss management treatment is custom designed for each patient based on their BMI and other needs
Physical activity recommendations include at least 150 minutes of moderate-intensity aerobic exercise weekly, combined with resistance training two to three times per week, individualized based on cardiovascular status and physical limitations
The goal is a gentler, steadier shift in appetite and metabolic signaling, with fewer side effects and a broader focus on overall wellbeing. As someone who chose the micro-dose route, I love that this approach is more gradual and holistic